Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Conflict of interest CR has received personal fees from Boehringer Ingelheim, GI Dynamics, Herbalife, Johnson and Johnson, Keyron, Eli Lilly, and Novo Nordisk outside the submitted work
Jan;12(1):37-51
In response to sitagliptin treatment, we observed the promotion of mitochondrial biogenesis and reversal of Warburg-type metabolism, which seems to be an underlying mechanism for its anti-cancer effects on the TNBC cell line
(PubMed) Teather LA, Wurtman RJ
US$ 28.73
US$ 28.41
US$ 24.62
